Who owns Carmell Therapeutics Corp - US?
- Ticker: CTCX
- CUSIP Number: 142922103
Tip: Access positions for across all investors
Analyze quarterly positions in Carmell Therapeutics Corp - US with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Carmell Therapeutics Corp - US stock
Who bought or sold Carmell Therapeutics Corp - US this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Meteora Capital | 1.7M | $4.5M | -2% | Mar 2024 |
|
| Vanguard Group | 173k | $442k | 2% | Mar 2024 |
|
| Carnegie Mellon University | 103k | $264k | 0% | Mar 2024 |
|
| Geode Capital Management | 90k | $230k | 45% | Mar 2024 |
|
| Northern Trust | 54k | $138k | 130% | Mar 2024 |
|
| BlackRock | 32k | $81k | 0% | Mar 2024 |
|
| XTX Topco | 14k | $36k | -37% | Mar 2024 |
|
| Hubbell Strickland Wealth Management | 13k | $32k | 100% | Mar 2024 |
|
| Morgan Stanley | 2.1k | $5.3k | 0% | Mar 2024 |
|
| Tower Research Capital | 1.3k | $3.3k | 48% | Mar 2024 |
|
| Royal Bank of Canada | 216.00 | $999.993600 | 222% | Mar 2024 |
|
| Wells Fargo & Company | 121.00 | $310.002000 | 2% | Mar 2024 |
|
| Jpmorgan Chase & Co | 7.00 | $17.999800 | 250% | Mar 2024 |
|
Who sold out of Carmell Therapeutics Corp - US?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Linden Advisors | Sep 2023 | 75k | $243M |
| Citadel Advisors | Dec 2023 | 15k | $56k |
| UBS Group | Dec 2023 | 690.00 | $2.6k |